Acorn Capital Advisors »

Jasper Therapeuritc shares owned by Acorn Capital Advisors

Quarter-by-quarter ownership of Jasper Therapeuritc (JSPR) shares owned by Acorn Capital Advisors from 13F filings

Historical chart of Acorn Capital Advisors investment in Jasper Therapeuritc

Tip: Access up to 7 years of quarterly data

All positions including Jasper Therapeuritc held by Acorn Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Jasper Therapeuritc by Acorn Capital Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $3.3M 1.4M 2.38

More positions owned by Acorn Capital Advisors

Cg Oncology (CGON)
Urogen Pharma (URGN)
Puma Biotechnology (PBYI)
Trevi Therapeutics (TRVI)
Terns Pharmaceuticals (TERN)
Candel Therapeutics (CADL)
Bicara Therapeutics (BCAX)
Onkure Therapeutics Class A Com (OKUR)
Protara Therapeutics Com Stk (TARA)
Verastem (VSTM)
Cybin Com New (CYBN)
Cardiff Oncology (CRDF)
Aura Biosciences (AURA)
Bioatla (BCAB)
Jasper Therapeuritc (JSPR)

View all positions for Acorn Capital Advisors

Top funds holding Jasper Therapeuritc

Velan Capital Investment Management
Soleus Capital Management
Acorn Capital Advisors
Kingdon Capital Management
Rock Springs Capital Management
Carlyle
Woodline Partners
Vanguard Group
T. Rowe Price Investment Management
Propel Bio Management
Qiming U.S. Ventures Management
Morgan Stanley
Citadel Advisors
Sphera Funds Management
Simplify Asset Management

View all funds holding Jasper Therapeuritc